AU2003302365A1 - Therapeutic oxidation catalysts - Google Patents
Therapeutic oxidation catalystsInfo
- Publication number
- AU2003302365A1 AU2003302365A1 AU2003302365A AU2003302365A AU2003302365A1 AU 2003302365 A1 AU2003302365 A1 AU 2003302365A1 AU 2003302365 A AU2003302365 A AU 2003302365A AU 2003302365 A AU2003302365 A AU 2003302365A AU 2003302365 A1 AU2003302365 A1 AU 2003302365A1
- Authority
- AU
- Australia
- Prior art keywords
- therapeutic
- oxidation catalysts
- catalysts
- oxidation
- therapeutic oxidation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C391/00—Compounds containing selenium
- C07C391/02—Compounds containing selenium having selenium atoms bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C395/00—Compounds containing tellurium
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0227348.0A GB0227348D0 (en) | 2002-11-22 | 2002-11-22 | Redox catalyst compositions |
GB0227348.0 | 2002-11-22 | ||
PCT/GB2003/005095 WO2004047925A2 (en) | 2002-11-22 | 2003-11-24 | Therapeutic oxidation catalysts |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003302365A1 true AU2003302365A1 (en) | 2004-06-18 |
Family
ID=9948379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003302365A Abandoned AU2003302365A1 (en) | 2002-11-22 | 2003-11-24 | Therapeutic oxidation catalysts |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003302365A1 (en) |
GB (1) | GB0227348D0 (en) |
WO (1) | WO2004047925A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009144253A1 (en) * | 2008-05-29 | 2009-12-03 | Karolinska Institutet Innovations Ab | Compounds comprising a 3-pyridinol or 5-pyrimidinol ring having an organoseleno or organotelluro substituent for use as antioxidants |
CN103086935B (en) * | 2011-10-28 | 2015-05-20 | 沈阳药科大学 | Diphenyl selenide, diphenyl selenoxide, diphenyl selenone compounds and uses thereof |
US11053236B2 (en) | 2016-06-21 | 2021-07-06 | The University Of Toledo | Substituted isoselenazolone anti-infective, anti-inflammatory, anti-cancer, cytoprotective, neuroprotective, and anti-oxidant agents |
CN114057619B (en) * | 2020-07-31 | 2024-03-22 | 深圳福山生物科技有限公司 | Organic selenium compounds and therapeutic uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9200502D0 (en) * | 1992-02-20 | 1992-02-20 | Astra Ab | NOVEL ANTIOXIDANTS |
-
2002
- 2002-11-22 GB GBGB0227348.0A patent/GB0227348D0/en not_active Ceased
-
2003
- 2003-11-24 WO PCT/GB2003/005095 patent/WO2004047925A2/en not_active Application Discontinuation
- 2003-11-24 AU AU2003302365A patent/AU2003302365A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004047925A3 (en) | 2004-10-28 |
GB0227348D0 (en) | 2002-12-31 |
WO2004047925A2 (en) | 2004-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003236906A1 (en) | Catalyst | |
AU2003206700A1 (en) | Catalyst | |
AU2003233738A1 (en) | Oxygen reduction catalyst | |
AU2003243777A1 (en) | Multi-zone catalytic converter | |
AU2003224725A1 (en) | Hiv therapeutic | |
AU2003217740A1 (en) | Non-invasive stationary system | |
AU2003216412A1 (en) | Catalyst carriers | |
AU2003212554A1 (en) | Steam-reforming catalytic structures | |
AUPS044502A0 (en) | Novel catalysts and processes for their preparation | |
AU2003283257A1 (en) | Scalp treatment | |
AU2003283626A1 (en) | Catheter | |
AU2003247005A1 (en) | Therapy combination | |
AU2003292403A1 (en) | Oxidation catalyst and its preparation | |
AU2003297207A1 (en) | Supported metal catalysts | |
AU2003284195A1 (en) | Olefin oxide catalysts | |
AU2003210257A1 (en) | Catalytic converter | |
AU2003245794A1 (en) | Glycosaminoglycan-dnase combination therapy | |
EP1655070A4 (en) | Oxidation catalyst | |
AU2003215150A1 (en) | Therapeutic compounds | |
AU2003263308A1 (en) | Catalysts | |
AU2002258956A1 (en) | Ship-in-a-bottle catalysts | |
AU2003302365A1 (en) | Therapeutic oxidation catalysts | |
AU2003244140A1 (en) | Catheter | |
AU2003256112A1 (en) | Patient bed | |
AU2003225401A1 (en) | Dl-hydroxy-alkyl-phenylamides having anticonvulsive activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |